FMR CORP 13D and 13G filings for Beam Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-02 11:02 am Purchase |
2025-03-31 | 13G | Beam Therapeutics Inc. BEAM |
FMR CORP | 10,042,092 10.100% |
4,602,759 (+84.62%) |
Filing |
| 2025-02-12 09:16 am Sale |
2024-12-31 | 13G | Beam Therapeutics Inc. BEAM |
FMR CORP | 5,439,333 6.600% |
-961,813 (-15.03%) |
Filing |
| 2024-11-12 09:50 am Sale |
2024-11-08 | 13G | Beam Therapeutics Inc. BEAM |
FMR CORP | 6,401,146 7.766% |
-2,552,654 (-28.51%) |
Filing |
| 2024-02-09 08:35 am Purchase |
2024-02-08 | 13G | Beam Therapeutics Inc. BEAM |
FMR CORP | 8,953,800 10.985% |
1,184,784 (+15.25%) |
Filing |
| 2023-02-09 08:14 am Purchase |
2023-02-09 | 13G | Beam Therapeutics Inc. BEAM |
FMR CORP | 7,769,016 11.024% |
1,779,318 (+29.71%) |
Filing |
| 2022-02-09 09:09 am Sale |
2022-02-08 | 13G | Beam Therapeutics Inc. BEAM |
FMR CORP | 5,989,698 8.790% |
-828,724 (-12.15%) |
Filing |
| 2022-01-24 08:40 am Sale |
2022-01-21 | 13G | Beam Therapeutics Inc. BEAM |
FMR CORP | 6,818,422 10.007% |
-510,164 (-6.96%) |
Filing |
| 2021-02-08 10:17 am Purchase |
2021-02-05 | 13G | Beam Therapeutics Inc. BEAM |
FMR CORP | 7,328,586 12.642% |
356,674 (+5.12%) |
Filing |